Royal Raymond Rife

Royal Raymond Rife (May 16, 1888 – August 5, 1971) was an American inventor and early exponent of high-magnification time-lapse cine-micrography who developed high-magnification microscopy technology and claimed in the 1930s to have identified a pleomorphic microorganism — the "BX virus" — as the universal cause of cancer, and to have developed a frequency-based electromagnetic device (the "Rife Machine") capable of destroying it without harming surrounding tissue — claims that were never independently replicated to the satisfaction of mainstream science, that brought him into conflict with the American Medical Association under Morris Fishbein, and that are cited in suppressed technology research as one of the clearest alleged cases of an effective medical technology being systematically suppressed by institutional medicine.

Rife is known for his microscopes, which he claimed could observe live microorganisms at magnifications considered impossible for his time, and for an "oscillating beam ray" invention, which he believed could treat various ailments by "devitalizing disease organisms" using radio waves. Although he came to collaborate with scientists, doctors, and inventors of the epoch, and his findings were published in newspapers and scientific journals, including the Smithsonian Institution annual report of 1944, they were later rejected by the American Medical Association (AMA), the American Cancer Society (ACS), and mainstream science.

Universal Microscope

Rife built a series of progressively more powerful microscopes beginning in the 1910s, culminating in the "Universal Microscope" of 1933 — a device of extraordinary complexity containing 5,682 parts by one account, incorporating both conventional optical elements and what Rife described as a heterodyning system using two light beams at slightly different frequencies to produce a third frequency (the difference tone) in the visible spectrum. Using a movie camera, Rife took time-lapse microscopy movies of microbes beginning in the late 1920s, and built microscopes that included polarizers. He claimed magnifications of 17,000× or more for some of the earlier instruments and effective magnification of up to 60,000 diameters with preserved specimen viability for the Universal Microscope — the target object remaining alive and unaltered during observation, unlike the electron microscopy developed contemporaneously by Knoll and Ruska, which requires specimens to be fixed (killed) and coated before examination.

The Smithsonian Institution's 1944 annual report described one of these microscopes as equipped for "transmitted and monochromatic beam dark-field, polarized, and slit-ultra illumination, including also a special device for crystallography", and added that several doctors had attended a demonstration and had been impressed by its clarity and high magnification. A distinctive feature of the microscopes, according to Rife and to other scientists who examined them, was a false-colour effect by which, when a microbe was illuminated by a particular wavelength of polarised monochromatic light, different for each type of microbe, the microbe and only the microbe would emit a distinctive colour of light (turquoise for typhoid bacteria, ruby red for Mycobacterium leprae, etc.), thus taking the place of staining and allowing otherwise difficult organisms to be plainly seen. The University of Southern California Medical School took official notice of Rife's work, and Rife was elected to the Franklin Institute and the Microscopy Society of Southern California.

The principal mainstream criticism of the Universal Microscope is that it appears to violate the Abbé diffraction limit — the physical constraint that the resolution of any optical instrument using visible light cannot exceed approximately half the wavelength of the light employed, roughly 200 nanometers for visible light. Rife maintained that his heterodyning approach circumvented this limit through a mechanism mainstream physics does not recognise. His claims have not been independently replicated to the satisfaction of mainstream optics researchers.

BX Virus and pleomorphism

Rife's microbiological framework rested on the theory of pleomorphism — the idea, controversial in mainstream bacteriology since the late 19th century, that microorganisms can radically change form (bacteria → viruses → larger forms) in response to environmental conditions. In mainstream germ theory (the Pasteur–Koch tradition), microorganisms are considered monomorphic: a bacillus remains a bacillus, a coccus remains a coccus.

Using his Universal Microscope, Rife claimed to observe a pleomorphic organism he designated the "BX" cancer virus, which he believed could transform between bacterial and viral forms depending on the pH and nutritional environment of its host tissue. He further claimed that all cancers were caused by this single organism in its viral phase, and that converting the tissue environment (by altering pH or electromagnetic frequency) could cause BX to convert to a non-pathogenic form — effectively curing cancer without destroying healthy tissue. Some of these observations are contradicted by modern mainstream microbiology: Rife reported that under certain conditions typhoid bacteria changed into a much smaller form, and he claimed that most cancerous tumours contained a microbe that had no less than five forms, one of which was indistinguishable from E. coli while another resembled a fungus. His principal microbiological collaborator was Dr. Arthur Kendall, then head of Northwestern University's Medical School, with whom he co-authored a 1931 paper in California and Western Medicine on the filterable state of Bacillus typhosus.

1934 clinical trial

In 1934, under the sponsorship of Dr. Milbank Johnson, a clinical trial was conducted at the Scripps Ranch near San Diego, California, treating sixteen terminally ill cancer patients using Rife's frequency device. All sixteen were reported to have achieved complete remission within three to four months. The trial was supervised by a Special Medical Research Committee composed of physicians from leading California medical institutions.

No peer-reviewed publication of these results occurred. Rife attributed this to the subsequent suppression campaign; critics attribute it to the absence of a controlled trial design, the lack of pathological confirmation of diagnoses, and the fact that none of the supervising physicians published independent accounts. The 1934 trial remains the strongest claimed evidence for Rife's treatment claims and the weakest in terms of documented methodology.

The Rife Machine

The core therapeutic device in Rife's system was a radio-frequency generator that exposed patients to electromagnetic energy at frequencies Rife called the "Mortal Oscillatory Rate" (MOR) for each target pathogen. The theory held that every microorganism has a characteristic resonant frequency, and that exposure to energy at that frequency will cause the organism to oscillate destructively — analogous to a soprano shattering a wine glass at the glass's resonant frequency — while leaving non-resonating human cells unaffected.

Rife identified MOR values for a range of pathogens, including the BX cancer virus (allegedly 11,780,000 Hz), tuberculosis bacillus, typhoid, pneumococcus, staphylococcus, and others. These frequencies have not been confirmed by any independent laboratory using replicated Rife equipment. According to the San Diego Evening Tribune in 1938, Rife stopped short of claiming that he could cure cancer, but did argue that he could "devitalize disease organisms" in living tissue, "with certain exceptions". In a 1931 Popular Science profile, Rife had himself warned against "medical fakers" who claim to cure disease using "electrical vibrations", stating that his work did not uphold such claims. Contemporary "Rife machine" products, sold widely in alternative health markets, use varied frequencies with no demonstrated relationship to Rife's original specifications.

Suppression narrative

The alleged suppression of Rife's work is the central claim of the alternative-medicine tradition that follows his legacy. The sequence described in Barry Lynes's The Cancer Cure That Worked and in Project Camelot's retrospective tribute is:

• 1934–1937: Rife's work gains credibility among California physicians; multiple doctors report successful cancer treatments; clinical momentum builds
• 1939: Morris Fishbein, editor of the Journal of the American Medical Association and effective head of the AMA, allegedly attempts to purchase a stake in Rife's technology; Rife declines
• 1939–1944: AMA-affiliated medical societies pressure physicians using the device; medical licences of cooperating doctors are revoked or threatened; Rife's primary collaborator, Dr. Arthur Kendall, is reportedly driven from his Northwestern post; Rife's laboratory associate Philip Hoyland files suit against the Beam Ray Corporation (the commercial entity manufacturing Rife devices), effectively destroying it
• 1944–1971: Rife's research funding collapses; his microscope becomes inaccessible; his documentation is dispersed or destroyed; Rife himself descends into poverty and alcoholism

An obituary in the Daily Californian described his death at the age of 83 on August 5, 1971, stating that he died penniless and embittered by the failure of his devices to garner scientific acceptance, and reported that Rife himself blamed the scientific rejection of his claims on a conspiracy involving the AMA, the Department of Public Health, and other elements of "organized medicine", which he said had "brainwashed and intimidated" his colleagues.

The parallels between the Rife suppression narrative and other documented cases of medical suppression — Harry Hoxsey's herbal cancer treatments, Wilhelm Reich's orgone research, Royal Lee's nutritional work — are cited by alternative-health researchers as evidence of a systematic pattern of institutional medicine eliminating competitive therapies that threatened pharmaceutical revenue.

Post-1987 revival and commercial Rife devices

Interest in Rife's claims was revived in alternative-medicine circles by the 1987 book by Barry Lynes, The Cancer Cure That Worked, which argued that Rife had succeeded in curing cancer but that his work was suppressed by a powerful conspiracy headed by the American Medical Association. The American Cancer Society described Lynes's claims as implausible, noting that the book was written "in a style typical of conspiratorial theorists", and that Lynes "cites names, dates, events and places, giving the appearance of authenticity to a mixture of historical documents and speculations selectively spun into a web far too complex to permit verification by anything short of an army of investigators with unlimited resources."

After the book's publication, a variety of devices bearing Rife's name were marketed as cures for diverse diseases including cancer and AIDS. Some used radio waves as in the original experiments; others used pulsed electric current or pulsed electromagnetic fields at what the manufacturers believed to be the correct frequencies. An analysis by Electronics Australia found that one typical 'Rife device' sold for AU$105 for a rudimentary circuit producing a tiny pulsed electrical current at a fixed frequency of about 40 kHz, consisting of a nine-volt battery, wiring, a switch, a standard 555 timer chip, and two short lengths of copper tubing meant to act as handheld electrodes — an arrangement the author described as nearly identical to the "zapper" device promoted by Hulda Clark, rather than having much in common with Rife's original devices, and only "the tip of an enormous iceberg" of commercial variants ranging in price from AU$1,500 to AU$34,000.

Prosecutions and mainstream medical assessments

Commercial Rife devices have figured in multiple U.S. health fraud prosecutions. In a 1996 case, the marketers of a Rife device claiming to cure numerous diseases including cancer and AIDS were convicted of felony health fraud; the sentencing judge described them as "target[ing] the most vulnerable people, including those suffering from terminal disease" and providing false hope. In 2002, John Bryon Krueger, who operated the Royal Rife Research Society, was sentenced to 12 years in prison for his role in a murder and received a concurrent 30-month sentence for illegally selling Rife devices. A Washington State couple, Donald and Sharon Brandt, who operated a clandestine health-care clinic from their home in Mount Vernon based on Rife's inventions, were convicted for a short imprisonment period. In 2009, James Folsom was convicted of 26 felony counts for selling Rife devices under the brand names 'NatureTronics', 'AstroPulse', 'BioSolutions', 'Energy Wellness', and 'Global Wellness'. Critics including Stephen Barrett have also reported that some cancer patients ceased chemotherapy and instead used these devices, with fatal outcomes. In Australia, the use of Rife machines has been blamed for the deaths of cancer patients who might have been treated with conventional therapy.

In 1994, the American Cancer Society's journal CA: A Cancer Journal for Clinicians criticized Rife's methods and devices in an article titled "Questionable Methods of Cancer Management: Electronic Devices", reporting that Rife machines were being sold in a "pyramid-like, multilevel marketing scheme", and noting that a key component in the marketing of Rife devices has been the claim, initially put forward by Rife himself, that the devices were being suppressed by an establishment conspiracy against cancer cures. Despite not being registered by the U.S. Food and Drug Administration and having been linked to cancer deaths, The Seattle Times reported that over 300 people attended the 2006 Rife International Health Conference in Seattle, where dozens of unregistered devices were sold. Cancer Research UK, the world's largest independent cancer research charity, has stated: "There is no reliable evidence that the Rife machine works as a cure for cancer... There is also no evidence that it doesn't cause harm... Many websites promote the Rife machine as a cure for cancer. But no reputable scientific cancer organisations support any of these claims." A 2000 article in The Sydney Morning Herald warned that "cancer sufferers have died after putting their faith in a device with electrical parts worth just $15", further reporting that Rife machines were "unanimously condemned as worthless by mainstream scientists and banned in at least two American States." Rife devices are currently classified by mainstream regulators as a subset of radionics devices, generally viewed as pseudomedicine.

Legacy and alternative health movement

Rife's work was largely forgotten by mainstream science by the 1950s. It was recovered and popularised in the 1980s by researcher Barry Lynes (The Cancer Cure That Worked, 1987) and subsequently by John Crane, Rife's laboratory assistant and equipment builder in the later years of his career. The publication of Lynes's book coincided with a broader alternative-health backlash against pharmaceutical oncology and initiated the contemporary "Rife machine" market.

The Project Camelot collective published an extended tribute to Rife, framing his case within their broader documentation of suppressed technology: "Rife's Universal Microscope was the only instrument capable of observing living viruses without destroying them. The electron microscope, which superseded it institutionally, cannot observe living specimens." This framing — that the less capable technology (electron microscopy) displaced the more capable one (Rife microscopy) because the more capable technology threatened institutional interests — is the core alternative-history claim about Rife's legacy.

As of 2026, commercial "Rife frequency" devices are sold in the alternative-health market worldwide; none have received FDA approval or produced peer-reviewed clinical evidence of efficacy for any condition. The original Universal Microscope, if it exists, has not been located.

Contemporary assessments

In a 2023 episode of EXOPOLITICS TODAY, Dan Willis — a former US Navy communications specialist turned alternative-science researcher — described Rife's work to host Michael Salla as follows: "Dr. Raymond Royal Rife, brilliant scientist. If you understand that everything in life has a frequency, everything has an oscillation. And if you pump too much of that frequency into whatever it is, it will explode. And so he was able — incredible genius — he made this microscope that could see the living organisms under the microscope and then he used the frequency oscillators... tuned through and found the Mortal Oscillatory Rate — the MOR is what he called it — when he hit that frequency, like for cancer or whatever, it destroyed it."

Willis further described the 1934 clinical trial outcome and the subsequent suppression: "In 1934 a special medical research committee was formed at the University of Southern California. The committee brought 16 terminally ill cancer patients who were near death from the Pasadena County Hospital to the laboratory of Rife to be treated with the Rife frequency generator. All 16 were cured of the cancer. Milbank Johnson, who organised this, was due to announce the results of the 1934 study of the 16 cancer patients who were reportedly cured. However, he never got to make that announcement. It was reported just hours before making the announcement he was fatally poisoned and his papers were lost." Michael Salla contextualised this within the broader pattern of Nikola Tesla's suppression, noting that the same institutional forces that neutralised Tesla's electromagnetic energy research in 1911–1914 allegedly applied equivalent pressure to Rife's clinical programme two decades later.

Salla extended this suppression pattern further, arguing that "the cabal and those in the pharmaceutical industry just do not want these technologies coming out — and not only will they kind of assassinate people, but they also orchestrate a world war to prevent this kind of stuff coming out": in his framing, the enthusiasm for electromagnetic medicine that characterised 1890–1914, when Tesla technologies were entering schools and Rife-precursor instruments were in wide use, was deliberately ended by the outbreak of WWI — after which all such modalities were "just swept aside." Rife's clinical programme of the 1930s represents, in Salla's reading, a second wave of the same advance, and its suppression via the AMA under Fishbein a second application of the same institutional mechanism. Willis added that the contemporary Rife machine market has a direct practical continuation in open-source frequency databases: he personally uses the Spooky2 system developed by John White, which he describes as offering "over 60,000 frequencies for just about everything" at affordable cost.

Project Camelot tribute account

The Project Camelot tribute page on Rife — one of the most widely-circulated summary accounts in the alternative-research community — describes the 1934 clinical trial as being sponsored by Dr. Milbank Johnson and supervised by a Special Medical Research Committee including physicians from leading California medical institutions, with all sixteen terminal patients achieving complete remission. Project Camelot further describes the November 1931 "End to All Diseases" banquet at Dr. Milbank Johnson's Pasadena estate, at which forty-four of the nation's most respected medical authorities honoured Rife — a gathering that, the tribute notes, was followed within eight years by nearly all attendees denying ever having met him, "the complete reversal the result of extremely heavy pressure from the drug companies."

The Project Camelot account adds several suppression details beyond those in Barry Lynes's The Cancer Cure That Worked: that on the eve of the press conference, Dr. Milbank Johnson was allegedly "fatally poisoned and his papers lost"; that Rife's laboratories were reportedly "destroyed by arson and sabotage" following Morris Fishbein's failed attempt to purchase the rights; that Dr. Nemes, who had independently duplicated Rife's work forty miles away, allegedly died in a "mysterious fire" destroying all his research papers; that the Burnett Laboratory, which was also validating Rife's work, was similarly destroyed by fire; and that Rife himself died in 1971 from "an 'accidental' lethal dose of Valium and alcohol at Grossmont Hospital."

Frequency therapy continuation

In a 2023 interview, inventor and alternative-health researcher James Schwartz described to Dr. Michael Salla his project to construct an immersive frequency-therapy chamber built on Rife principles. Schwartz expressed frustration with commercially available "Rife generators" on the grounds that hand-held or foot-contact devices deliver frequency through the path of least electrical resistance rather than through internal organs: "These Royal Rife generators are a joke as far as I'm concerned because they go through one hand, through the other, and off the other side — they don't get to the organs of the body." Schwartz's proposed solution was total water immersion, allowing Rife frequencies to penetrate uniformly through the body's fluid medium rather than via surface contact — a modification he described as still inferior to med bed technology but superior to existing commercial Rife devices.

Rife and the Flexner Report: electromagnetic medicine foreclosed

Documentary filmmaker Jesse Michels and alternative-medicine researcher Ross Douthat have situated Rife's suppression within the longer arc of the Flexner Report (1910) — the Carnegie Foundation-commissioned review that standardised American medical education around a single biochemical, pharmaceutical paradigm. Douthat notes that before the Flexner Report, roughly a third of American doctors were practitioners of homeopathy, osteopathy, and electromagnetic field medicine; after it, all such modalities were effectively driven from accredited institutions. Douthat connects this directly to the commercial logic of Rife's suppression: "if we do find an answer around the Rife machine, Royal Rife was a little conspiratorial about his work being marginalized — that all of a sudden becomes this great open source thing and everybody can treat each other on the electromagnetic field and you know, there's less room for big pharma."

Michels describes the Rife Machine's mechanism in terms accessible to a modern audience: "The simplest explanation for how it works is that it's creating a frequency that shakes and shatters bacteria in the way that an opera singer's voice at a particular note can shatter glass." Michels, who used a Rife machine himself as treatment for Lyme disease, describes experiencing empirical benefit that "traditional medicine" had failed to provide — framing his personal case as data on a technology that remains outside the double-blind, placebo-controlled trial model that Western medicine requires but that electromagnetic therapies are structurally unsuited to satisfy within that methodology.

Jesse Michels: suppressed electromagnetic medicine and the broader pattern

In a 2025 episode of American Alchemy with Jesse Michels with guest Brigham Buhler, Michels presented Rife's work within a broader survey of dismissed electromagnetic medicine — linking it to the observation that electromagnetic fields appear to be causally upstream of DNA in developmental biology: experiments placing frog embryos in Faraday cages show abnormal development, and cell gradient experiments on tadpole limbs demonstrate that body morphology can be altered by manipulating bioelectric fields independent of genetics. Michels' framing positions Rife's frequency-based pathogen destruction not as fringe pseudoscience but as one application within a broader electromagnetic biology paradigm that mainstream medicine has allegedly excluded since 1910 — a suppression pattern he explicitly parallels to the institutional suppression of UAP research.

See also

• Med beds
• Albert Abrams
• Electromagnetic therapy (alternative medicine)
• List of ineffective cancer treatments
• Medical applications of radio frequency

References

This article incorporates material from the Wikipedia article "Royal Rife", as of 2024-12-24, released under the Creative Commons Attribution-ShareAlike 4.0 License.